Branco Lab

Karolinska Institute

Östra Sverige (SE1) · Sweden

ERC-funded
Rate this labNo reviews yet — be the first.

Research focus

ERC Advanced Grant · 2022

Unveiling the functional outcome of single nucleotide polymorphisms and variants in oligodendroglia in multiple sclerosis

Multiple sclerosis (MS) is a neurological disease characterized by autoimmune attack targeting oligodendroglia (OLG) in the central nervous system (CNS), and in particular their myelin, which ensheaths neuronal axons. Genome-wide association studies (GWAS) have led to the identification of hundreds of single-nucleotide polymorphisms (SNPs) and variants that are associated with MS risk. Many of these are located near genes associated with immune cells, indicating a key role for these cells in MS. Using single-cell omics approaches, we recently found that OLG present chromatin accessibility or express genes associated with some of these SNPs/variants, both in health and disease. Here, we…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.

Reviews

← All labs at Karolinska Institute